Molecular Profiles of Advanced Urological Cancers in the PERMED-01 Precision Medicine Clinical Trial

SIMPLE SUMMARY: The goal of precision medicine is to deliver therapy matched to a relevant actionable genetic alteration (AGA) identified in the tumor. Few data are available regarding precision medicine in advanced urological cancers (AUC), the prognosis of which remains unfavorable. Sixty-four pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Billon, Emilien, Gravis, Gwenaelle, Guille, Arnaud, Carbuccia, Nadine, Adelaide, Jose, Garnier, Séverine, Finetti, Pascal, Denicolaï, Emilie, Sfumato, Patrick, Brunelle, Serge, Thomassin-Piana, Jeanne, Pignot, Géraldine, Walz, Jochen, Chabannon, Christian, Pakradouni, Jihane, Sabatier, Renaud, Vicier, Cécile, Popovici, Cornel, Mamessier, Emilie, Gonçalves, Anthony, Birnbaum, Daniel, Chaffanet, Max, Bertucci, François
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9100924/
https://www.ncbi.nlm.nih.gov/pubmed/35565404
http://dx.doi.org/10.3390/cancers14092275

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9100924/
https://www.ncbi.nlm.nih.gov/pubmed/35565404
http://dx.doi.org/10.3390/cancers14092275

Ejemplares similares